
    
      The aim of this study is to evaluate the efficacy of doxycycline in relapsed Cutaneous T-cell
      Lymphomas (CTCL). The primary objective is to determine the overall response rate of
      doxycycline monotherapy in patients with relapsed CTCL.
    
  